Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.66 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.63 |
| ▸ | TYR | P14679 | 1/20 | 0.63 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.63 |
| ▸ | ERN1 | O75460 | 3/20 | 0.58 |
| ▸ | PRKDC | P78527 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.48 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | NQO2 | P16083 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethane SCHEMBL28205235 | 0.98 | ALDH1A1 (0.63) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| SCHEMBL1134243 | 0.88 | ALDH1A1 (0.53) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| SCHEMBL584683 | 0.86 | ERN1 (0.61) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| SCHEMBL24313342 | 0.85 | PRKDC (0.48) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| SCHEMBL29558007 | 0.85 | PRKDC (0.48) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| Bromide SCHEMBL27667716 | 0.84 | ERN1 (0.59) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| SCHEMBL12672585 | 0.83 | ALDH1A1 (0.70) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| SCHEMBL29957021 | 0.83 | ALDH1A1 (0.70) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| SCHEMBL20535326 | 0.82 | PRKDC (0.47) | ALDH1A1TRIM24TYRTRIM33ERN1 | |
| SCHEMBL15145284 | 0.81 | LMNA (0.59) | ALDH1A1TRIM24TYRTRIM33ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115108989-B | Resveratrol derivative and preparation method and application thereof | 山东大学 | 2024-04-05 | — | — | CN | claimed |
| CN-115536509-B | Synthesis method of 2-bromo-4-hydroxybenzaldehyde | 苏州当量生物医药有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-115536509-A | Synthesis method of 2-bromo-4-hydroxybenzaldehyde | 苏州金蚕新材料科技有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-115108989-A | Resveratrol derivative and preparation method and application thereof | 山东大学 | 2022-09-27 | — | — | CN | claimed |
| CN-106632070-B | A kind of preparation method of PDE4 inhibitor chlorine than Pulan | 广州兰晟健智医药科技有限公司 | 2019-08-06 | — | — | CN | claimed |
| CN-109608374-A | 1,4- dihydroxy-anthracene naphthoquinone derivatives and its preparation method and application | 广西大学 | 2019-04-12 | — | — | CN | claimed |
| CN-107628925-A | A kind of preparation method of 2 phenyl halogenation methylbenzene and its derivative | 中国石油化工股份有限公司 | 2018-01-26 | — | — | CN | claimed |
| CN-107118087-A | A kind of new technique for synthesizing of isovanillin | 蚌埠中实化学技术有限公司 | 2017-09-01 | — | — | CN | claimed |
| CN-106632070-A | Preparation method for chlorbipram PDE4-inhibitor | 徐江平 | 2017-05-10 | — | — | CN | claimed |
| CN-106243104-A | One is to naphthoquinone and pyrimidine heterozygote and synthetic method thereof | 新乡医学院 | 2016-12-21 | — | — | CN | claimed |
| CN-106188099-A | A kind of 1,4 sulfur nitrogen Zhuo derivant and synthetic methods thereof | 新乡医学院 | 2016-12-07 | — | — | CN | claimed |
| CN-103360315-B | Heterocyclic aryloxyacetyl hydrazone derivative and its preparation method and application thereof | UNIV SHANDONG | 2015-03-04 | — | — | CN | claimed |
| CN-101921587-B | Fluorescent probe having tumor cell proliferation inhibition activity and preparation method thereof | UNIV XI AN JIAOTONG | 2014-07-02 | — | — | CN | claimed |
| CN-101240166-B | Bromobenzothiazoles luminous agent and preparation method thereof | UNIV JIANGNAN | 2010-09-29 | — | — | CN | claimed |
| CN-101240166-A | Bromobenzothiazoles luminous agent and preparation method thereof | UNIV JIANGNAN (CN) | 2008-08-13 | — | — | CN | claimed |
| EP-4161642-B1 | N-PHENYLAMINOCARBONYL PYRIDINO- , PYRIMIDINO AND BENZO-TROPANES AS MODULATORS OF GPR65 | PATHIOS THERAPEUTICS LTD (GB) | 2026-05-27 | — | — | EP | disclosed |
| US-12624035-B2 | Compounds for targeted protein degradation | AMPHISTA THERAPEUTICS LIMITED (GB) | 2026-05-12 | — | — | US | disclosed |
| US-4730068-A | SPECIAL EFFECT ON BREAST CANCER | ASTA-WERKE AKTIENGESELLSCHAFT (DE) | 1988-03-08 | — | — | US | disclosed |
| CN-86100815-A | The preparation method who suppresses (1, the 2-diphenyl ethylene diamine)-platinum (II) complex compound of tumour | — | 1986-11-26 | — | — | CN | disclosed |
| EP-0193055-A1 | Antitumorals(1,2-diphenyl-ethylene diamine)-platinum (II) complexes | ASTA Pharma AG (DE) | 1986-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624035-B2 | Compounds for targeted protein degradation | BRD9, BRD1, BRD3 | ALDH1A1 4325/4885TRIM24 472/4885TYR 2321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.